Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells
about
Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive reviewEfficacy of an Anti-transferrin Receptor 1 Antibody Against AIDS-related Non-Hodgkin Lymphoma: A Brief Communication.Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor MiceUpdate on obinutuzumab in the treatment of B-cell malignancies.Postulated mechanisms of resistance of B-cell non-Hodgkin lymphoma to rituximab treatment regimens: strategies to overcome resistance.New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.
P2860
Q27304386-CC338EDB-93E7-4384-B056-D6574308A569Q36117093-8E65865F-C6F8-4CD1-8CA7-CDE3E13B5E85Q37434315-5D707D0D-6F86-4546-8853-A36023845DB7Q38246230-F79AB5F5-ECC1-4943-8CE9-91BAD5D9BEF6Q38273851-38478F26-D768-4FF9-B258-28CB9798E37CQ38714354-537B18AA-DA9D-45EF-81D6-06F2F2946E8BQ38935082-87BE3EBE-1097-49CF-97A1-3CC4762C7703Q41387926-FB02CC66-5D66-48A4-9791-8DFB04E1063BQ44877649-E01BF9FE-AA60-4F1F-A544-DF8B35DA01EEQ55283747-EE712CAC-12C8-4A49-8D77-1B0C2B054F89
P2860
Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Analysis of innate and acquire ...... gnant and nonmalignant B cells
@en
Analysis of innate and acquire ...... nant and nonmalignant B cells.
@nl
type
label
Analysis of innate and acquire ...... gnant and nonmalignant B cells
@en
Analysis of innate and acquire ...... nant and nonmalignant B cells.
@nl
prefLabel
Analysis of innate and acquire ...... gnant and nonmalignant B cells
@en
Analysis of innate and acquire ...... nant and nonmalignant B cells.
@nl
P2093
P2860
P356
P1433
P1476
Analysis of innate and acquire ...... gnant and nonmalignant B cells
@en
P2093
George W Small
Howard L McLeod
Kristy L Richards
P2860
P356
10.7717/PEERJ.31
P577
2013-02-12T00:00:00Z